Clinical Trials Browser

Recruiting × Endometrial Neoplasms × avelumab × Clear all

NCT06518564 2026-01-07

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms